Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
  • Science
    • Dark biodiversity
    • New antimicrobials
    • Beyond antimicrobials
  • R&D
    • Innovation engine overview
    • Extracting microbial biodiversity
    • Screening for new activity
    • Active compound characterization
    • Preindustrial production
    • Preclinical development
    • Clinical development
  • Technologies
    • Technology platform overview
    • Biodiversity farming
    • Activity testing
    • Advanced analytics
    • Synthetic biology
    • Data Science
    • Fermentation engineering
    • Bioprocess engineering
  • Pipeline
  • Partnering
    • New antimicrobials
    • Beyond antimicrobials
  • Investors
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News
    • Press releases
    • Events
  1. Home
  2. Investors
  3. Press releases

Press releases

14.01.2013

DEINOVE announces its financial calendar for 2013

DEINOVE (Alternext Paris: ALDEI) announces today its provisional financial calendar for 2013.* March 21, 2013: Publication of 2012 Annual...
11.01.2013

Report on DEINOVE’S liquidity contract with BIL Finance

Under the liquidity contract entrusted by DEINOVE to BIL Finance, the following assets appeared on the liquidity account as at December 31...
18.09.2012

Half-year financial results as of June 30, 2012

The net cash position of € +7.1m at the end of June 2012 covers the needs of the company’s ongoing R&D programmes at least through to...
31.07.2012

DEINOVE Appoints Julien Coste as Director of Finance & Administration

DEINOVE (Alternext Paris: ALDEI), the green technology company and world specialist in the development of deinococcus bacteria for the...
03.07.2012

Bilan semestriel du contrat de liquidité contracté avec BIL FINANCE

La société DEINOVE (Code ISIN : FR0010879056 – Mnémonique : ALDEI) annonce qu’au titre du contrat de liquidité confié par la société...
15.06.2012

Résiliation et mise en oeuvre d'un contrat de liquidité avec la société Dexia Securities France

La société DEINOVE (Code ISIN : FR0010879056 – Mnémonique : ALDEI) confie à DEXIA SECURITIES FRANCE la mise en œuvre d’un contrat de...
28.03.2012

Assemblée Générale des Actionnaires le 3 Mai 2012 à 11h à l’Hôtel Crown Plaza Place de la République 75010 - Paris

12.03.2012

DEINOVE awarded OSEO Innovative Company status and FCPI certification

Deinove (Alternext Paris: ALDEI), a green technology company and the world’s leading specialist in Deinococcus bacteria for biofuels and...
17.02.2012

DEINOVE SA Financial results to December 31st 2011

Deinove (Alternext Paris: ALDEI), the world's leading specialist in Deinococcus bacteria for biofuels and green chemistry, today published...
05.01.2012

Bilan annuel du contrat de liquidité DEINOVE contracté avec DEXIA SECURITIES FRANCE

Au titre du contrat de liquidité portant sur les actions de la société DEINOVE, confié à DEXIA SECURITIES FRANCE par le FCPR Truffle...
  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »

Investors

  • Corporate governance
    • Board of Directors
    • Executive Committee
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
    • Financial Reports
    • Investors slide deck
    • Analyst Coverage
    • Number of Shares and Voting Rights
    • Newsletter to Shareholders
    • Shareholders' Meetings
    • Declaration of transactions performed on company securities
    • Liquidity Agreement
    • Public offerings - Documentation
    • Bonds Convertible into Shares (OCA)
  • Press releases
  • Investor relations
  • Careers
  • Contact
  • Legal Info
  • Site map
  • Privacy Policy

Follow us

         

Stay in touch

Subscribe to our newsletter

Contact us

Location

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home